News|Articles|February 3, 2026
Turning Abandonment Scenarios into Patient Starts
Author(s)CoverMyMeds
Discover three strategies for overcoming high costs, prior authorization delays and rejected claims.
Related Content
Trending on PharmExec
1
Artisan Partners’ Director Calls for Novartis Board Shake-Up
2
340B Under Pressure: Inside Pharma's Push for Greater Clarity
3
The Agentic AI Revolution in Biopharma
4
Kura Oncology Spins Out Caspian Therapeutics With $50 Million to Test Menin Inhibition as a Disease-Modifying Approach to Diabetes
5